After He Jiankui's Case: Chinese Legislative Modifications in Human Embryo Gene Editing
- 14 November 2022
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 33 (21-22) , 1121-1125
Abstract
This article systematically discusses Chinese current legal status and rules for human embryo gene editing in both administrative law and criminal law after several legislative modifications, and further systematically evaluates the values and the defects of these modifications. After He Jiankui's case, Chinese legislators devoted themselves to improve human embryo gene editing legislation. As a result, human embryo gene editing's legal status becomes more determined. Rules for human embryo gene editing in Chinese administrative law have gradually become a complete system centering on “ CBL-regulation ,” and the promulgation of Amendment (XI) to the Criminal Law reconciles the controversy existed in academic circles. Chinese rules for human embryo gene editing are moving from “doubtful development” to “complete legal system.”Keywords
This publication has 4 references indexed in Scilit:
- Germline genome editing: Moratorium, hard law, or an informed adaptive consensus?PLOS Genetics, 2021
- Ethical and regulatory issues in human gene editing: Chinese perspectiveBiotechnology and Applied Biochemistry, 2020
- CRISPR’d babies: human germline genome editing in the ‘He Jiankui affair’*Journal of Law and the Biosciences, 2019
- Human Embryo Gene Editing in China: The Uncertain Legal Status of the EmbryoBioSocieties, 2018